A majority of 340B hospitals surveyed said the costs associated with implementing drugmakers’ proposed rebate models would hinder their ability [...] …
Category: Pharma Industry
Three patient groups are urging a federal appeals court to back drugmaker 340B rebate models they argue would bring transparency [...] …
Two major drugmakers recently announced new states that will be exempt from their 340B contract pharmacy restrictions following their enactment [...] …
Three drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2022 and 2025 following recalculations of [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
News Alert
Matsui, Welch Reintroduce 340B PATIENTS Act in Congress During 340B Coalition Summer Conference
The two congressional Democrats behind the 340B PATIENTS Act—a 2024 federal bill that would’ve codified providers’ ability to use 340B [...] …
A key federal regulator highlighted the Health Resources and Services Administration’s (HRSA) legal fight against proposed drugmaker 340B rebate models [...] …
The leader of a major 340B hospital trade group heralded the forthcoming reintroduction of a federal bill that would codify [...] …
A Washington, D.C. federal appellate court on Friday consolidated multiple drug industry appeals challenging the government’s authority to preapprove 340B [...] …
Two major drugmakers announced new changes to their 340B contract pharmacy restrictions in notices posted to 340B ESP’s website late [...] …